Sofosbuvir/Pegylated-interferon Plus Ribavirin With HCV Genotype 4
NCT04382339
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
99
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C Virus Infection
Interventions
DRUG:
SOF/RBV/PegINFα-2
Sponsor
Beni-Suef University